Pfizer Stock: Company Halts Obesity-Drug Development. What It Means for Eli Lilly, Novo Nordisk. – Barron’s
- Pfizer Stock: Company Halts Obesity-Drug Development. What It Means for Eli Lilly, Novo Nordisk. Barron’s
- Pfizer scraps daily weight loss pill after liver injury in one patient CNBC
- Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron Business Wire
- Pfizer Abandons Obesity Pill After Liver Injury in Setback Bloomberg.com
- Pfizer Halts Development of Weight-Loss Pill WSJ
